“…This stigma is found to be related to the general conception of a frequent connection between cirrhosis and the harmful use of alcohol and, not least, to the frequent presence of cognitive impairment caused by HE (Agrawal, Umapathy, & Dhiman, 2015; Montagnese & Bajaj, 2019). The characteristics of this patient group call for a healthcare system focused on providing easy and timely patient access (McAfee, 2012), continuity and familiarity with staff, frequent support, and patient education (Beg, Curtis, & Shariff, 2016; Goodman et al, 2021), as well as close follow-up (Freundlich Grydgaard & Bager, 2018; Langberg & Taddei, 2016). Initiatives like these, often referred to as chronic disease management programs, have limited prevalence in hepatology and cirrhosis treatment (Wigg, Chinnaratha, Wundke, & Volk, 2015).…”